The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Atmadibrata, Bernard ^a   Liu, Pei Y ^a   Sokolowski, Nicolas ^a   Zhang, Lihong ^a,b   Wong, Matthew ^a   Tee, Andrew E ^a   Marshall, Glenn M ^a,c   Liu, Tao ^a,d  

^a CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^b FUDAN UNIVERSITY   (China)

^c SYDNEY CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; LUCIFERASE; MESSENGER RNA; MYC PROTEIN; SMALL INTERFERING RNA; DKK1 PROTEIN, HUMAN; EYE PROTEIN; RD3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENETIC TRANSFECTION; LINC00467 GENE; LUCIFERASE ASSAY; MICROARRAY ANALYSIS; NEUROBLASTOMA CELL; PROMOTER REGION; RD3 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; TUMOR SUPPRESSOR GENE; GENETICS; HUMAN; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; EYE PROTEINS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MYC; RNA, LONG NONCODING; RNA, MESSENGER;

EID: 84896755763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088112     Document Type: Article

References (33)

1. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369: 2106-2120. (Pubitemid 46935947)
2. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
3. Eilers M, Eisenman RN (2008) Myc's broad reach. Genes Dev 22: 2755-2766.
4. Meyer N, Penn LZ (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8: 976-990.
5. Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, et al. (2010) Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene 29: 5957-5968.
6. Marshall GM, Liu PY, Gherardi S, Scarlett CJ, Bedalov A, et al. (2011) SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet 7: e1002135.
7. Liu T, Tee AE, Porro A, Smith SA, Dwarte T, et al. (2007) Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proc Natl Acad Sci U S A 104: 18682-18687. (Pubitemid 350210757)
8. Liu PY, Xu N, Malyukova A, Scarlett CJ, Sun YT, et al. (2013) The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ 20: 503-514.
9. Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10: 155-159.
10. Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136: 629-641.
11. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, et al. (2010) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419.
12. Takayama KI, Horie-Inoue K, Katayama S, Suzuki T, Tsutsumi S, et al. (2013) Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J.
13. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, et al. (2013) The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73: 1180-1189.
14. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076.
15. Dang CV (2013) MYC on the path to cancer. Cell 149: 22-35.
16. Hosgood HD 3rd, Zhang L, Shen M, Berndt SI, Vermeulen R, et al. (2009) Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. Occup Environ Med 66: 848-853.
17. Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, et al. (2006) The DNA sequence and biological annotation of human chromosome 1. Nature 441: 315-321. (Pubitemid 44050191)
18. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, et al. (2004) The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res 14: 2121-2127. (Pubitemid 39440194)
19. Suzuki Y, Yamashita R, Shirota M, Sakakibara Y, Chiba J, et al. (2004) Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions. Genome Res 14: 1711-1718. (Pubitemid 39276428)
20. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, et al. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A 99: 16899-16903. (Pubitemid 36034070)
21. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, et al. (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472: 120-124.
22. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, et al. (2010) Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58.
23. Garding A, Bhattacharya N, Claus R, Ruppel M, Tschuch C, et al. (2013) Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-kB. PLoS Genet 9: e1003373.
24. Shou J, Ali-Osman F, Multani AS, Pathak S, Fedi P, et al. (2002) Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene 21: 878-889. (Pubitemid 34146301)
25. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, et al. (2011) Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer 128: 1793-1803.
26. Batista PJ, Chang HY (2013) Long noncoding RNAs: cellular address codes in development and disease. Cell 152: 1298-1307.
27. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, et al. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693.
28. Lai F, Orom UA, Cesaroni M, Beringer M, Taatjes DJ, et al. (2013) Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 494: 497-501.
29. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, et al. (2013) Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 9: e1003368.
30. Johnsson P, Ackley A, Vidarsdottir L, Lui WO, Corcoran M, et al. (2013) A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 20: 440-446.
31. Friedman JS, Chang B, Kannabiran C, Chakarova C, Singh HP, et al. (2006) Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration. Am J Hum Genet 79: 1059-1070. (Pubitemid 44853477)
32. Peshenko IV, Olshevskaya EV, Azadi S, Molday LL, Molday RS, et al. (2011) Retinal degeneration 3 (RD3) protein inhibits catalytic activity of retinal membrane guanylyl cyclase (RetGC) and its stimulation by activating proteins. Biochemistry 50: 9511-9519.
33. Liu T, Liu PY, Tee AEL, Haber M, Norris MD, et al. (2009) Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors. European Journal of Cancer 45: 1846-1854.